Glycyx
About Us
Our Science
For Patients
For Investors
Contact
More
Is to significantly improve survival rates and enhance the quality of life for cancer patients worldwide. We focus on developing therapies to ensure that essential pain management does not compromise the effectiveness of cancer treatments.
Justin Chickles
Chief Executive Officer
Lorin Johnson, PhD
Chief Scientific Officer
David Taggart
Chief Business Officer
Bridget Martell
Chief Medical Officer
Jonathan Moss, MD, PhD
Medical Advisor